Steve Duffy

Most Recent Articles by Steve Duffy

Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury

Cannabidiol Gets Orphan Drug Status for Preventing Ischemia-Reperfusion Injury

By

The designation was granted to Revive Therapeutics, a company that specializes in cannabis-based pharmaceuticals.

Lasmiditan NDA Submitted for Acute Treatment of Migraine

Lasmiditan NDA Submitted for Acute Treatment of Migraine

By

The NDA submission included data from two Phase 3 trials, SAMURAI and SPARTAN.

FDA Clears Patient Controller Platform for Stimwave's Neuromodulation Device

FDA Clears Patient Controller Platform for Stimwave's Neuromodulation Device

By

The new software enables patients to fine-tune the power level and modify programs that were pre-programmed by their clinician to control pain.

FDA Issues Safety Communication Regarding Pen Needle Use

FDA Issues Safety Communication Regarding Pen Needle Use

By

Standard pen needles have an outer cover and removable inner needle cover, while safety pen needles have an outer cover and a fixed inner needle shield that is not removed before an injection.

NDA Submitted for Valtoco Nasal Spray to Treat Acute Repetitive Seizures

NDA Submitted for Valtoco Nasal Spray to Treat Acute Repetitive Seizures

By

The Company states that the NDA is supported by robust clinical trial data, including patients studies where more than 1600 seizures were treated with Valtoco nasal spray.

More Articles by Steve Duffy

Sign Up for Free e-newsletters



CME Focus